共 50 条
- [1] A non-covalent inhibitor with pan-KRAS potentialNature Reviews Drug Discovery, 2023, 22 : 622 - 622Katie Kingwell
- [2] A PAN-KRAS INHIBITOR IMPEDES COMMON KRAS ONCOPROTEINS AND TUMOR GROWTHCANCER DISCOVERY, 2023, 13 (08) : 1757 - 1757Kim, D.Herdeis, L.Rudolph, D.Zhao, Y.Bottcher, J.Vides, A.
- [3] Pan-KRAS inhibitor disables oncogenic signalling and tumour growthNATURE, 2023, 619 (7968) : 160 - +Kim, DongsungHerdeis, LorenzRudolph, DorotheaZhao, YuleiBoettcher, JarkVides, AlbertoAyala-Santos, Carlos I. I.Pourfarjam, YasinCuevas-Navarro, AntonioXue, Jenny Y.Mantoulidis, AndreasBroeker, JoachimWunberg, TobiasSchaaf, OtmarPopow, JohannesWolkerstorfer, BernhardKropatsch, Katrin GabrieleQu, Ruide Stanchina, ElisaSang, BenLi, ChuanchuanMcConnell, Darryl B. B.Kraut, NorbertLito, Piro
- [4] Pan-KRAS inhibitor disables oncogenic signalling and tumour growthNature, 2023, 619 : 160 - 166Dongsung KimLorenz HerdeisDorothea RudolphYulei ZhaoJark BöttcherAlberto VidesCarlos I. Ayala-SantosYasin PourfarjamAntonio Cuevas-NavarroJenny Y. XueAndreas MantoulidisJoachim BrökerTobias WunbergOtmar SchaafJohannes PopowBernhard WolkerstorferKatrin Gabriele KropatschRui QuElisa de StanchinaBen SangChuanchuan LiDarryl B. McConnellNorbert KrautPiro Lito
- [5] Pan-KRAS destruction with a single PROTACNATURE BIOTECHNOLOGY, 2024, 42 (10) : 1499 - 1499Marchal, Iris
- [6] Structurally-Diverse Non-Covalent Allosteric KRAS Inhibitors Structurally Diverse Non-Covalent Allosteric KRAS InhibitorsBIOPHYSICAL JOURNAL, 2020, 118 (03) : 324A - 324APagba, CynthiaGupta, Amit K.McCarthy, MichaelZhou, YongGorfe, Alemayehu A.
- [7] A pan-KRAS degrader for the treatment of KRAS-mutant cancersCELL DISCOVERY, 2024, 10 (01)Yang, JieWang, Qiao-LiWang, Guan-NanYe, Jia-CongLi, Zi-QianWang, Jing-YunLiang, Zhao-HuiLi, Shu-XinSun, CongLiao, Wen-TingGao, Yi-JunWang, JingMao, YongYu, ChunjingFeng, Guo-KaiZeng, Mu-Sheng
- [8] Targeting cancer with small-molecule pan-KRAS degradersSCIENCE, 2024, 385 (6715) : 1338 - 1347Popow, JohannesFarnaby, WilliamGollner, AndreasKofink, ChristianeFischer, GerhardWurm, MelanieZollman, DavidWijaya, AndreMischerikow, NikolaiHasenoehrl, CarinaProkofeva, PolinaArnhof, HeribertArce-Solano, SilviaBell, SammyBoeck, GeorgDiers, EmelyneFrost, Aileen B.Goodwin-Tindall, JakeKarolyi-Oezguer, JaleKhan, ShakilKlawatsch, TheresaKoegl, ManfredKousek, RolandKratochvil, BarbaraKropatsch, KatrinLauber, Arnel A.Mclennan, RossOlt, SabinePeter, DanielPetermann, OliverRoessler, VanessaStolt-Bergner, PeggyStrack, PatrickStrauss, EvaTrainor, NicoleVetma, VesnaWhitworth, ClaireZhong, SiyingQuant, JensWeinstabl, HaraldKuster, BernhardEttmayer, PeterCiulli, Alessio
- [9] Cytotoxicity of combinations of the pan-KRAS inhibitor BAY-293 against primary non-small lung cancer cellsTRANSLATIONAL ONCOLOGY, 2021, 14 (12):Plangger, AdelinaRath, BarbaraHochmair, MaximilianFunovics, MartinHamilton, Gerhard
- [10] Resistance to the Non-Covalent BTK Inhibitor PirtobrutinibBLOOD, 2022, 140 : 6981 - 6982Naeem, Aishath S.Utro, FilippoWang, QingCha, JustinVihinen, MaunoMartindale, Stephen P.Zhou, YingluTyekucheva, SvitlanaKim, Annette S.Fernandes, Stacey M.Fardoun, RayanSaksena, GordonRhrissorrakrai, KahnLevovitz, ChayaDanysh, Brian P.Slowik, KaraJacobs, RaquelDavids, Matthew S.Zain, RulaSmith, Edvard C., ILeshchiner, IgnatyParida, LaxmiGetz, GadBrown, Jennifer R.